Publications by authors named "N A Al Laham"

Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a difficult to treat organism owing to limited therapeutic options. So far, little is known about the molecular characteristics of CRKP in Palestine.

Objectives: The aim of this study was to investigate the antimicrobial resistance patterns, multilocus sequence types (ST) and resistance genes among clinical K.

View Article and Find Full Text PDF
Article Synopsis
  • The study highlights the growing issue of multi-drug resistance in Gram-negative bacteria, specifically focusing on extended-spectrum beta-lactamases (ESBL) in a pediatric hospital in Gaza.
  • A total of 158 clinical isolates were analyzed, with 93 (58.9%) found to be ESBL positive, indicating a significant prevalence particularly in urine and pus samples.
  • Whole-genome sequencing revealed that these ESBL-producing isolates carried multiple antibiotic resistance genes, underscoring the need for effective surveillance and treatment strategies.
View Article and Find Full Text PDF

Background: The ongoing global crisis of Higher Education (HE) institutions during the post-COVID-19 pandemic period has increased the likelihood of enduring psychological stressors for staff. This study aimed to identify factors associated with job insecurity, burnout, psychological distress and coping amongst staff working at HE institutions globally.

Methods: An anonymous cross-sectional study was conducted in 2023 with staff at HE institutions across 16 countries.

View Article and Find Full Text PDF

Background: The fecal carriage of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) is a major driver of the global spread of these antibiotic resistance determinants. Here we determined the rate of fecal ESBL-PE carriage in pediatric hospitals and community-serving healthcare centers serving adults and children in the Gaza Strip, Palestine.

Methods: A total of 373 fecal and rectal samples were collected from different hospitals and clinics in Gaza.

View Article and Find Full Text PDF

Background And Aim: Colistin is used to treat avian pathogenic (APEC), a microorganism that affects turkey meat production in the Gaza Strip and worldwide. However, the recent emergence of plasmid-borne mobile colistin resistance () genes in pathogenic strains is a serious antimicrobial resistance (AMR) challenge for both human and animal health. In December 2018, colistin was banned as a veterinary antimicrobial in the Gaza Strip.

View Article and Find Full Text PDF